• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

US: Newer HIV therapies have led to gains in viral suppression rates over past 2 decades

Shiloh

Editor, Senior Moderator
Source: https://eurekalert.org/pub_releases/2018-08/acop-nht081418.php

Public Release: 20-Aug-2018
Newer HIV therapies have led to gains in viral suppression rates over past 2 decades

American College of Physicians

1. Newer HIV therapies have led to dramatic gains in viral suppression rates over the past 2 decades

Younger persons and blacks saw lower rates of improvement

Abstract: http://annals.org/aim/article/doi/10.7326/M17-2242

Editorial: http://annals.org/aim/article/doi/10.7326/M18-1944

URLs go live when the embargo lifts

Viral suppression rates have nearly tripled in the U.S. over the past 2 decades, but disparities still exist for younger persons and blacks living with HIV. Researchers say that newer, better-tolerated treatment regimens, such as fixed-drug combinations that include integrase strand transfer inhibitors (ISTIs), have likely contributed to these dramatic gains. Findings from an observational cohort study are published in Annals of Internal Medicine.

Approximately 1.2 million adults in the U.S. are living with HIV, and men who have sex with men and African Americans are disproportionately affected. Achieving and maintaining HIV viral suppression is essential for optimal outcomes and prevention efforts. As such, understanding trends and predictors of viral suppression is imperative to inform public health policy...
 
Back
Top